Evidence map›Paper›PMID 38605875›Full record

ArticleFrontiers in public health2024

Medical cost of breast cancer services in Serbia between 2010 and 2019: national data report.

Nemanja Rancic, Milos Todorovic, Milos Stepovic, Stefan Vekic, Dejan Kostic, Milena Ratkovic, Svetlana Radevic, Radoje Simic, Viktorija Dragojevic Simic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nemanja RancicCentre for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.
Milos TodorovicMedical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia.
Milos StepovicDepartment of Anatomy, Faculty of Medical Science, University of Kragujevac, Kragujevac, Serbia.
Stefan VekicFaculty of Economics, University of Belgrade, Belgrade, Serbia.
Dejan KosticMedical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia.
Milena RatkovicDepartment for Quality Management, Plan and Analysis, Military Medical Academy, Belgrade, Serbia.
Svetlana RadevicDepartment of Social Medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Radoje SimicDepartment for Plastic Surgery, Institute for Mother and Child Health Care of Serbia Dr. Vukan Cupic, Belgrade, Serbia.
Viktorija Dragojevic SimicCentre for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsDrug CostsFemaleHumansSerbiabreast cancerchemotherapydiagnosticsmedical costspharmacoeconomic

Identifiers

PMID38605875
PMCPMC11007175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.